Tectonic Therapeutic Inc. (TECX) Key Metrics
TECX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $403.7M
- Enterprise value
- $265.5M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 2.2
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.38
TECX key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsTECX valuation Price multiples at each fiscal year-end price.
TECX returns How much profit the business earns on the capital it uses.
TECX per-share figures Results divided by the shares outstanding at year-end.
TECX financial health Debt, liquidity and how easily interest is covered.
TECX valuation history
TECX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
TECX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
TECX price vs earnings per share
TECX key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $382.2M | $681.9M | — | — | — | — | — | — | — | — |
| Enterprise value | $129.7M | $543.9M | — | — | — | — | — | — | — | — |
| Price / book | 1.5 | 4.8 | — | — | — | — | — | — | — | — |
| Earnings yield | −19.4% | −8.5% | — | — | — | — | — | — | — | — |
| Free cash flow yield | −15.8% | −8.7% | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $20.86 | $46.17 | $16.32 | $8.55 | $46.20 | $167.28 | $241.56 | $199.80 | — | — |
| Per share | ||||||||||
| Revenue per share | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Earnings per share | −$4.05 | −$3.93 | — | — | — | — | — | — | — | — |
| Operating cash flow per share | −$3.28 | −$4.00 | — | — | — | — | — | — | — | — |
| Free cash flow per share | −$3.29 | −$4.01 | — | — | — | — | — | — | — | — |
| Cash per share | $13.85 | $9.56 | — | — | — | — | — | — | — | — |
| Book value per share | $13.72 | $9.53 | — | — | — | — | — | — | — | — |
| Tangible book value per share | $13.72 | $9.53 | — | — | — | — | — | — | — | — |
| Capex per share | $0.01 | $0.01 | — | — | — | — | — | — | — | — |
| Debt per share | $0.07 | $0.22 | — | — | — | — | — | — | — | — |
| Shares outstanding | 18.3M | 14.8M | — | — | — | — | — | — | — | — |
| Change in shares outstanding | +24.1% | — | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −37.8% | −206.6% | — | — | — | −54.4% | −47.3% | −73.9% | −479.0% | −105.5% |
| Return on assets (ROA) | −35.8% | −60.3% | −98.9% | −80.4% | −5.9% | −50.8% | −43.7% | −66.0% | −300.2% | −86.4% |
| Return on tangible assets | −28.4% | −37.9% | −108.7% | −68.2% | −27.2% | −44.1% | −36.4% | −34.7% | −265.6% | −86.4% |
| Financial health | ||||||||||
| Total debt | $1.3M | $3.3M | $4.3M | $5.8M | $1.1M | — | — | — | — | — |
| Cash & short-term investments | $253.8M | $141.2M | $28.8M | $36.0M | $28.1M | $259.7M | $187.0M | $126.3M | $6.0M | $5.4M |
| Net debt | −$252.5M | −$137.9M | −$24.4M | −$30.2M | −$27.0M | −$259.7M | −$187.0M | −$126.3M | −$6.0M | −$5.4M |
| Debt / equity | 0.01 | 0.02 | — | — | — | — | — | — | — | — |
| Debt / assets | 0.00 | 0.02 | 0.11 | 0.12 | 0.03 | — | — | — | — | — |
| Current ratio | 26.63 | 12.65 | 0.76 | 4.73 | 6.95 | 16.09 | 13.96 | 12.26 | 2.40 | 6.03 |
| Quick ratio | 26.63 | 12.65 | 0.76 | 4.73 | 6.95 | 16.09 | 13.96 | 12.26 | 2.40 | 6.03 |
| Interest coverage | — | -542.2 | -293.7 | -228.0 | -69.7 | — | — | — | — | — |
| Working capital | $247.7M | $135.2M | −$10.0M | $29.2M | $24.5M | $250.6M | $181.7M | $119.4M | $3.7M | $4.5M |
| Invested capital | −$1.2M | $2.8M | −$109.1M | −$75.8M | −$42.0M | −$5.3M | −$1.0M | −$4.1M | −$2.6M | −$936,000 |
| Tangible asset value | $251.3M | $140.8M | −$84.6M | −$45.7M | −$15.0M | $254.3M | $186.0M | $122.2M | $3.4M | $4.4M |
| Net current asset value | $247.7M | $134.7M | −$93.2M | −$55.8M | −$19.2M | $250.4M | $181.2M | $118.7M | $2.7M | $4.4M |
| Graham net-net per share | $13.32 | $8.74 | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Capex / depreciation | 0.15 | 0.09 | 0.19 | 0.27 | 5.83 | 0.98 | 1.86 | 4.82 | 8.51 | — |
| Efficiency | ||||||||||
| Days payables outstanding | — | 153.7 | 290.8 | 104.3 | 585.7 | 1,002.6 | 1,445.6 | 1,590.2 | 3,516.2 | — |
| Receivables turnover | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Payables turnover | — | 2.38 | 1.26 | 3.50 | 0.62 | 0.36 | 0.25 | 0.23 | 0.10 | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | — | — | — | $1.5M | $2.6M | $2.4M | $1.8M | $1.5M | — | — |
| Average payables | $1.0M | $692,500 | $491,500 | $1.2M | $2.2M | $3.3M | $3.4M | $1.7M | $433,500 | $340,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from TECX's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
TECX valuation and financial ratios
Tectonic Therapeutic earned a return on equity of −37.8% in fiscal 2025. It ended the year with $1.3 million of debt and $253.8 million in cash and short-term investments, a net cash position of $252.5 million.
See the TECX income statement, the TECX chart for price history, or the TECX stock overview for the latest quote and news.
TECX key metrics FAQ
What is Tectonic Therapeutic's return on equity?
Tectonic Therapeutic's return on equity (ROE) was −37.8% in fiscal 2025: net income of -$74.2 million on average shareholders' equity of $196.1 million.
How much debt does Tectonic Therapeutic have?
Tectonic Therapeutic had total debt of $1.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.01 and more cash than debt.
What is Tectonic Therapeutic's free cash flow yield?
Tectonic Therapeutic generated -$60.3 million of free cash flow in fiscal 2025, a free cash flow yield of −15.8% on its market value at year-end ($382.2 million).
What is Tectonic Therapeutic's current ratio?
Tectonic Therapeutic's current ratio was 26.63 at the end of fiscal 2025: current assets were 26.63 times current liabilities.